Suppr超能文献

幽门螺杆菌对赤桉和托雷氏桉提取物的体外敏感性。

In vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana.

作者信息

Adeniyi Christiana Bola A, Lawal Temitope Olufunmilayo, Mahady Gail B

机构信息

Department of Pharmaceutical Microbiology, University of Ibadan, Ibadan, Nigeria.

出版信息

Pharm Biol. 2009 Jan 1;47(1):99-102. doi: 10.1080/13880200802448708.

Abstract

The in vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis Dehnh. and Eucalyptus torelliana F. Muell. (Myrtaceae), Nigerian medicinal plants, was investigated in six strains of H. pylori, namely, ATCC 4504, ATCC 47619, A2, TI8984, 019A, and A6. The susceptibility of these strains was determined using a standardized agar dilution method (National Committee for Clinical Laboratory Standards guidelines) with Mueller-Hinton agar, supplemented with defibrinated horse blood. The minimum inhibitory concentrations of the crude extracts against all the tested strains ranged from 12.5 to 400 mug/mL. Phytochemical screening of the plant extracts revealed the presence of tannins, saponins, and cardenolides. The anti-H. pylori activities demonstrated by these plants may be attributed to their chemical constituents, and explain their reported traditional uses, as well as their gastroprotective properties as demonstrated previously in experimental animals. The results of this work suggest that, in accordance with their traditional medical use in Nigeria, E. camaldalensis and E. torelliana have some therapeutic potential against H. pylori, and thus are of interest for the treatment of H. pylori infections.

摘要

研究了尼日利亚药用植物——赤桉(Eucalyptus camaldulensis Dehnh.)和托雷氏桉(Eucalyptus torelliana F. Muell.)(桃金娘科)提取物对幽门螺杆菌的体外敏感性,受试的6株幽门螺杆菌分别为ATCC 4504、ATCC 47619、A2、TI8984、019A和A6。采用标准化琼脂稀释法(依据美国国家临床实验室标准委员会指南),以添加去纤维马血的Mueller-Hinton琼脂测定这些菌株的敏感性。粗提物对所有受试菌株的最低抑菌浓度范围为12.5至400μg/mL。对植物提取物进行的植物化学筛选显示含有单宁、皂苷和强心苷。这些植物所表现出的抗幽门螺杆菌活性可能归因于其化学成分,这也解释了它们已报道的传统用途以及先前在实验动物中所证明的胃保护特性。这项研究结果表明,根据它们在尼日利亚的传统医学用途,赤桉和托雷氏桉对幽门螺杆菌具有一定的治疗潜力,因此在幽门螺杆菌感染治疗方面具有研究价值。

相似文献

3
Combination studies of Eucalyptus torelliana F. Muell. leaf extracts and clarithromycin on Helicobacter pylori.
Phytother Res. 2012 Sep;26(9):1393-8. doi: 10.1002/ptr.3719. Epub 2012 Feb 8.
8
Ellagitannin Oligomers from Leaves and Their Role in the Detoxification of Aluminum.
Molecules. 2025 May 19;30(10):2216. doi: 10.3390/molecules30102216.
9
Susceptibility of Helicobacter pylori to metronidazole.
Am J Gastroenterol. 2003 Oct;98(10):2157-61. doi: 10.1111/j.1572-0241.2003.07681.x.

引用本文的文献

1
The Ethnopharmacology, Phytochemistry and Bioactivities of the Genus (Myrtaceae).
Plants (Basel). 2023 Oct 25;12(21):3686. doi: 10.3390/plants12213686.
3
Plants against to combat resistance: An ethnopharmacological review.
Biotechnol Rep (Amst). 2020 May 21;26:e00470. doi: 10.1016/j.btre.2020.e00470. eCollection 2020 Jun.
4
Antimicrobial activity of Dehn. plant extracts and essential oils: A review.
Ind Crops Prod. 2019 Jun;132:413-429. doi: 10.1016/j.indcrop.2019.02.051. Epub 2019 Mar 5.
5
and Its Antibiotic Heteroresistance: A Neglected Issue in Published Guidelines.
Front Microbiol. 2019 Aug 13;10:1796. doi: 10.3389/fmicb.2019.01796. eCollection 2019.
6
Antibacterial Properties of Flavonoids from Kino of the Eucalypt Tree, Corymbia torelliana.
Plants (Basel). 2017 Sep 14;6(3):39. doi: 10.3390/plants6030039.

本文引用的文献

1
4
Antibiotic resistance problems with Helicobacter pylori.
Int J Antimicrob Agents. 1999 Jun;12(1):19-26. doi: 10.1016/s0924-8579(99)00051-5.
5
The prevalence of Helicobacter pylori in peptic ulcer disease.
Aliment Pharmacol Ther. 1995;9 Suppl 2:59-69.
7
Campylobacter pyloridis and gastritis.
J Infect Dis. 1986 Apr;153(4):650-7. doi: 10.1093/infdis/153.4.650.
8
Characterization of urease from Campylobacter pylori.
J Clin Microbiol. 1988 May;26(5):831-6. doi: 10.1128/jcm.26.5.831-836.1988.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验